2型糖尿病患者糖尿病肾病与常规临床参数的剂量反应关联:一项系统评价和荟萃分析

Dose-response association of diabetic kidney disease with routine clinical parameters in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

作者信息

Guo Jianbo, Liu Chen, Wang Yifan, Shao Baoyi, Fong Tung Leong, Lau Ngai Chung, Zhang Hui, Li Haidi, Wang Jianan, Lu Xinyu, Wang Anqi, Leung Cheuk Lung, Chia Xin Wei, Li Fei, Meng Xiaoming, He Qingyong, Chen Haiyong

机构信息

School of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

出版信息

EClinicalMedicine. 2024 Feb 13;69:102482. doi: 10.1016/j.eclinm.2024.102482. eCollection 2024 Mar.

Abstract

BACKGROUND

Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease and is associated with high mortality rates. The influence of routine clinical parameters on DKD onset in patients with type 2 diabetes mellitus (T2DM) remains uncertain.

METHODS

In this systematic review and meta-analysis, we searched multiple databases, including PubMed, Embase, Scopus, Web of Science, and Cochrane Library, for studies published from each database inception until January 11, 2024. We included cohort studies examining the association between DKD onset and various clinical parameters, including body mass index (BMI), hemoglobin A1c (HbA1c), systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and serum uric acid (UA). Random-effect dose-response meta-analyses utilizing one-stage and/or cubic spline models, were used to estimate correlation strength. This study is registered in PROSPERO (CRD42022326148).

FINDINGS

This analysis of 46 studies involving 317,502 patients found that in patients with T2DM, the risk of DKD onset increased by 3% per 1 kg/m increase in BMI (relative risk (RR) = 1.03, confidence interval (CI) [1.01-1.04], I = 70.07%; GRADE, moderate); a 12% increased risk of DKD onset for every 1% increase in HbA1c (RR = 1.12, CI [1.07-1.17], I = 94.94%; GRADE, moderate); a 6% increased risk of DKD onset for every 5 mmHg increase in SBP (RR = 1.06. CI [1.03-1.09], I = 85.41%; GRADE, moderate); a 2% increased risk of DKD onset per 10 mg/dL increase in TG (RR = 1.02, CI [1.01-1.03], I = 78.45%; GRADE, low); an 6% decreased risk of DKD onset per 10 mg/dL increase in HDL (RR = 0.94, CI [0.92-0.96], I = 0.33%; GRADE, high), and a 11% increased risk for each 1 mg/dL increase in UA (RR = 1.11, CI [1.05-1.17], I = 79.46%; GRADE, moderate). Subgroup analysis revealed a likely higher risk association of clinical parameters (BMI, HbA1c, LDL, and UA) in patients with T2DM for less than 10 years.

INTERPRETATION

BMI, HbA1c, SBP, TG, HDL and UA are potential predictors of DKD onset in patients with T2DM. Given high heterogeneity between included studies, our findings should be interpreted with caution, but they suggest monitoring of these clinical parameters to identify individuals who may be at risk of developing DKD.

FUNDING

Shenzhen Science and Innovation Fund, the Hong Kong Research Grants Council, and the HKU Seed Funds, and Scientific and technological innovation project of China Academy of Chinese Medical Sciences.

摘要

背景

糖尿病肾病(DKD)是终末期肾病的主要病因,且与高死亡率相关。常规临床参数对2型糖尿病(T2DM)患者DKD发病的影响仍不确定。

方法

在这项系统评价和荟萃分析中,我们检索了多个数据库,包括PubMed、Embase、Scopus、Web of Science和Cochrane图书馆,以查找从每个数据库创建至2024年1月11日发表的研究。我们纳入了队列研究,这些研究考察了DKD发病与各种临床参数之间的关联,包括体重指数(BMI)、糖化血红蛋白(HbA1c)、收缩压(SBP)、舒张压(DBP)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)和血清尿酸(UA)。采用单阶段和/或三次样条模型的随机效应剂量反应荟萃分析来估计关联强度。本研究已在国际前瞻性系统评价注册库(PROSPERO,注册号CRD42022326148)登记。

结果

这项对46项研究(涉及317,502例患者)的分析发现,在T2DM患者中,BMI每增加1kg/m²,DKD发病风险增加3%(相对危险度(RR)=1.03,置信区间(CI)[1.01 - 1.04],I² = 70.07%;证据质量等级,中等);HbA1c每增加1%,DKD发病风险增加12%(RR = 1.12,CI [1.07 - 1.17],I² = 94.94%;证据质量等级,中等);SBP每增加5mmHg,DKD发病风险增加6%(RR = 1.06,CI [1.03 - 1.09],I² = 85.41%;证据质量等级,中等);TG每增加10mg/dL,DKD发病风险增加2%(RR = 1.02,CI [1.01 - 1.03],I² = 78.45%;证据质量等级,低);HDL每增加10mg/dL,DKD发病风险降低6%(RR = 0.94,CI [0.92 - 0.96],I² = 0.33%;证据质量等级,高),UA每增加1mg/dL,DKD发病风险增加11%(RR = 1.11,CI [1.05 - 1.17],I² = 79.46%;证据质量等级,中等)。亚组分析显示,病程小于10年的T2DM患者中,临床参数(BMI、HbA1c、LDL和UA)的风险关联可能更高。

解读

BMI、HbA1c、SBP、TG、HDL和UA是T2DM患者DKD发病的潜在预测因素。鉴于纳入研究之间存在高度异质性,我们的研究结果应谨慎解读,但它们提示监测这些临床参数以识别可能有发生DKD风险的个体。

资助

深圳市科技创新基金、香港研究资助局、香港大学种子基金以及中国中医科学院科技创新项目。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89ff/10875261/b8e6b66443f6/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索